F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.
Singulair, now a generic, is still used by millions of people in the United States even after thousands of patients and dozens of studies have described harm.
El Paxlovid reduce el riesgo de muerte por covid, pero no todos los que lo necesitan lo toman
Al aumentar las muertes por covid, los investigadores se preguntan por qué en EE. UU. el uso del medicamento ha seguido siendo bajo entre los pacientes de alto riesgo.
Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth
The maker of Zepbound and Mounjaro launched a new platform to connect patients and prescribers.
F.D.A. to Issue First Approval for Mass Drug Imports to States from Canada
The agency plans to authorize Florida to purchase medicines directly from wholesalers in Canada, where prices are far cheaper. Pharmaceutical companies oppose the plan.
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.
With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.
Millions Die of Malaria With Miracle Drugs at Hand
Vaccines are available and could be widely distributed if governments paid for them.
Sidney M. Wolfe, Scourge of the Pharmaceutical Industry, Dies at 86
For over 40 years, he and his organization, the Health Research Group, held government and manufacturers to account for unsafe medication.
Resistencia a los antibióticos: lo que hay que saber
Se calcula que el 28 por ciento de los antibióticos recetados a niños y adultos son innecesarios. En esta temporada, aprende cómo usarlos (y cuándo es mejor evitarlos).
A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicine
An A.L.S. drug rejected by the F.D.A. made me rethink how doctors should give hope to patients.
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research
In a wide-ranging interview, Dr. Monica M. Bertagnolli, the director of the National Institutes of Health, discussed drug patents, trust in science and her own experience as a cancer patient.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.